Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Mark E. Bardgett"'
Autor:
Amy Ashworth, Mark E. Bardgett, Jocelyn Fowler, Helen Garber, Molly Griffith, Christine Perdan Curran
Publikováno v:
Toxics, Vol 3, Iss 1, Pp 1-17 (2014)
The C57BL/6 (B6) mouse is the background strain most frequently used for genetically-modified mice. Previous studies have found significant behavioral and genetic differences between the B6J (The Jackson Laboratory) and B6N substrains (National Insti
Externí odkaz:
https://doaj.org/article/a3b5dfde490444bb89798070960c51eb
Publikováno v:
Behavioural Brain Research. 362:64-70
Antipsychotic drugs are used to manage symptoms of pediatric psychiatric disorders despite the relative absence of research regarding the long-term effects of these drugs on brain development. Using rats as a model, research has demonstrated that adm
Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference
Autor:
James R. Pauly, Brittany T. Muncie, Emily C. Baltes Thompson, Sara A. Steffen, Mark E. Bardgett, Casey Crane, Justin R. Yates, Tyler Downnen
Publikováno v:
Neuropharmacology
Risperidone is an atypical antipsychotic drug used increasingly in children to manage symptoms of ADHD and conduct disorder. In rats, developmental risperidone administration is accompanied by increased locomotor activity during adulthood, as well as
Publikováno v:
European Journal of Pharmacology. 812:256-263
Antipsychotic drug prescriptions for pediatric populations have increased over the past 20 years, particularly the use of atypical antipsychotic drugs such as risperidone. Most antipsychotic drugs target forebrain dopamine systems, and early-life ant
Publikováno v:
Behavioural Pharmacology. 27:460-469
Early-life administration of risperidone, the most widely used antipsychotic drug in children, leads to persistently elevated locomotor activity in adult rats. This study determined if and when elevated locomotor activity emerges during developmental
Publikováno v:
Biological Psychiatry. 87:S279
Autor:
Matthew A. Gannon, Cecile A. Marczinski, Molly S. Griffith, Rachel M. Stevens, Clifford J. Brown, Mark E. Bardgett
Publikováno v:
Pharmacology Biochemistry and Behavior. 130:90-96
Risperidone is an antipsychotic drug that is approved for use in childhood psychiatric disorders such as autism. One concern regarding the use of this drug in pediatric populations is that it may interfere with social interactions that serve to nurtu
Autor:
Cecile A. Marczinski, Amy L. Stamates, Mark E. Bardgett, Julianne Ossege, Sarah F. Maloney, Clifford J. Brown
Publikováno v:
Journal of Caffeine Research. 4:57-63
Background: Energy drinks and energy shots are popular consumer beverages that are advertised to increase feelings of alertness. Typically, these products include high levels of caffeine, a mild psychostimulant drug. The scientific evidence demonstra
Autor:
Molly S. Griffith, Kathleen R. Juneau, Julie M. Franks-Henry, Cecile A. Marczinski, Rachel M. Stevens, Mark E. Bardgett, Kristin R. Colemire
Publikováno v:
Experimental and Clinical Psychopharmacology. 21:259-267
Risperidone is an antipsychotic drug approved for use in children, but little is known about the long-term effects of early-life risperidone treatment. In animals, prolonged risperidone administration during development increases forebrain dopamine r
Publikováno v:
Alcoholism: Clinical and Experimental Research. 35:1282-1292
Background: There has been a dramatic rise in the consumption of alcohol mixed with energy drinks (AmED) in young people. AmED have been implicated in risky drinking practices and greater accidents and injuries have been associated with their consump